{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T12:53:07Z","timestamp":1792068787455,"version":"4.4.0"},"reference-count":169,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T00:00:00Z","timestamp":1771372800000},"content-version":"vor","delay-in-days":163,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T00:00:00Z","timestamp":1757289600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,12,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Heart failure (HF) is a multifactorial and pathophysiological complex syndrome, involving not only neurohormonal activation but also oxidative stress, chronic low-grade inflammation, and metabolic derangements. Central to the cellular defence against oxidative damage is nuclear factor erythroid 2-related factor 2 (Nrf2), a transcription factor that orchestrates antioxidant and cytoprotective responses. Preclinical in vitro and in vivo studies reveal that Nrf2 signalling is consistently impaired in HF, contributing to the progression of myocardial dysfunction. The loss of Nrf2 activity intersects a complex network of pathological processes involving neurohormonal activation, ischaemia\u2013reperfusion injury, and sustained inflammation, exacerbating cardiac functional decline. Nrf2 deficiency diminishes resilience to clinical conditions such as hypertension, diabetic cardiomyopathy, and cancer therapy-related cardiotoxicity, favouring the transition from initial cardiac dysfunction to overt HF. Initial evidence supports the therapeutic potential of Nrf2 modulation. Lifestyle interventions such as exercise training, various natural compounds, and established cardiovascular agents (e.g. sodium-glucose cotransporter-2 inhibitors) have been shown to restore Nrf2 activity. This review analyses the emerging role of Nrf2 as both a key player in HF pathogenesis and a promising therapeutic target, highlighting available evidence across HF phenotypes and addressing the controversies surrounding its pharmacological modulation.<\/jats:p>","DOI":"10.1002\/ehf2.15406","type":"journal-article","created":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T09:41:40Z","timestamp":1757324500000},"page":"4000-4020","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["The Emerging Role of Nrf2 in Heart Failure: From Cardioprotection to Therapeutic Approaches"],"prefix":"10.1093","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8749-8558","authenticated-orcid":false,"given":"Emiliano","family":"Fiori","sequence":"first","affiliation":[{"name":"Cardiovascular Center, AZORG , Aalst ,","place":["Belgium"]},{"name":"Department of Clinical and Molecular Medicine, Sapienza University , Rome ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Davinelli","sequence":"additional","affiliation":[{"name":"Department of Medicine and Health Sciences \u201cV. Tiberio\u201d, University of Molise , Campobasso ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armando","family":"Ferrera","sequence":"additional","affiliation":[{"name":"Institute of Medicine and Sport Science, National Italian Olympic Committee , Rome ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Medoro","sequence":"additional","affiliation":[{"name":"Department of Medicine and Health Sciences \u201cV. Tiberio\u201d, University of Molise , Campobasso ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Barsali","sequence":"additional","affiliation":[{"name":"Department of Clinical and Molecular Medicine, Sapienza University , Rome ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allegra","family":"Battistoni","sequence":"additional","affiliation":[{"name":"Department of Clinical and Molecular Medicine, Sapienza University , Rome ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Volterrani","sequence":"additional","affiliation":[{"name":"Cardiology Department, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) San Raffaele Roma , Rome ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Volpe","sequence":"additional","affiliation":[{"name":"Department of Clinical and Molecular Medicine, Sapienza University , Rome ,","place":["Italy"]},{"name":"Cardiology Department, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) San Raffaele Roma , Rome ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luciano","family":"Saso","sequence":"additional","affiliation":[{"name":"Department of Physiology and Pharmacology \u201cVittorio Erspamer\u201d, Sapienza University , Rome ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Speranza","family":"Rubattu","sequence":"additional","affiliation":[{"name":"Department of Clinical and Molecular Medicine, Sapienza University , Rome ,","place":["Italy"]},{"name":"IRCCS Neuromed , Pozzilli, IS ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,9,8]]},"reference":[{"key":"2026021804181373600_ehf215406-bib-0001","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1177\/2047487319870344","article-title":"Oxidative stress and inflammation in the evolution of heart failure: from pathophysiology to therapeutic strategies","volume":"27","author":"Aimo","year":"2020","journal-title":"Eur J Prev Cardiol"},{"key":"2026021804181373600_ehf215406-bib-0002","doi-asserted-by":"publisher","DOI":"10.1016\/j.cpcardiol.2023.102084","article-title":"Natural allies for heart health: Nrf2 activation and cardiovascular disease management","volume":"49","author":"Khan","year":"2024","journal-title":"Curr Probl Cardiol"},{"key":"2026021804181373600_ehf215406-bib-0003","doi-asserted-by":"publisher","first-page":"857","DOI":"10.2174\/1568026615666150220114417","article-title":"Regression of oxidative stress by targeting eNOS and Nrf2\/ARE signaling: a guided drug target for cardiovascular diseases","volume":"15","author":"Ramprasath","year":"2015","journal-title":"Curr Top Med Chem"},{"key":"2026021804181373600_ehf215406-bib-0004","doi-asserted-by":"publisher","DOI":"10.1007\/s10571-024-01487-0","article-title":"Sleep and oxidative stress: current perspectives on the role of NRF2","volume":"44","author":"Davinelli","year":"2024","journal-title":"Cell Mol Neurobiol"},{"key":"2026021804181373600_ehf215406-bib-0005","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1134\/S0006297924100031","article-title":"Computational assessment of carotenoids as Keap1-Nrf2 protein-protein interaction inhibitors: implications for antioxidant strategies","volume":"89","author":"Medoro","year":"2024","journal-title":"Biochemistry (Mosc)"},{"key":"2026021804181373600_ehf215406-bib-0006","doi-asserted-by":"publisher","DOI":"10.3390\/cells11010012","article-title":"MiR-140-5p attenuates hypoxia-induced breast cancer progression by targeting Nrf2\/HO-1 axis in a Keap1-independent mechanism","volume":"11","author":"Mahajan","year":"2021","journal-title":"Cells"},{"key":"2026021804181373600_ehf215406-bib-0007","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/j.bcp.2012.11.016","article-title":"The Nrf2 cell defence pathway: Keap1-dependent and -independent mechanisms of regulation","volume":"85","author":"Bryan","year":"2013","journal-title":"Biochem Pharmacol"},{"key":"2026021804181373600_ehf215406-bib-0008","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/s41573-018-0008-x","article-title":"Therapeutic targeting of the NRF2 and KEAP1 partnership in chronic diseases","volume":"18","author":"Cuadrado","year":"2019","journal-title":"Nat Rev Drug Discov"},{"key":"2026021804181373600_ehf215406-bib-0009","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1016\/j.freeradbiomed.2022.11.017","article-title":"Targeting NRF2-KEAP1 axis by Omega-3 fatty acids and their derivatives: emerging opportunities against aging and diseases","volume":"193","author":"Davinelli","year":"2022","journal-title":"Free Radic Biol Med"},{"key":"2026021804181373600_ehf215406-bib-0010","doi-asserted-by":"publisher","DOI":"10.1016\/j.abb.2019.108073","article-title":"HO-1 overexpression and underexpression: clinical implications","volume":"673","author":"Drummond","year":"2019","journal-title":"Arch Biochem Biophys"},{"key":"2026021804181373600_ehf215406-bib-0011","doi-asserted-by":"publisher","first-page":"2597","DOI":"10.1007\/s11010-023-04878-x","article-title":"NRF2 signaling pathway and telomere length in aging and age-related diseases","volume":"479","author":"Medoro","year":"2024","journal-title":"Mol Cell Biochem"},{"key":"2026021804181373600_ehf215406-bib-0012","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1093\/toxsci\/kfr183","article-title":"Beneficial role of Nrf2 in regulating NADPH generation and consumption","volume":"123","author":"Wu","year":"2011","journal-title":"Toxicol Sci"},{"key":"2026021804181373600_ehf215406-bib-0013","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.mam.2008.05.005","article-title":"Regulation of glutathione synthesis","volume":"30","author":"Lu","year":"2009","journal-title":"Mol Asp Med"},{"key":"2026021804181373600_ehf215406-bib-0014","doi-asserted-by":"publisher","first-page":"3381","DOI":"10.1073\/pnas.0400282101","article-title":"Decline in transcriptional activity of Nrf2 causes age-related loss of glutathione synthesis, which is reversible with lipoic acid","volume":"101","author":"Suh","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"2026021804181373600_ehf215406-bib-0015","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms11624","article-title":"Nrf2 suppresses macrophage inflammatory response by blocking proinflammatory cytokine transcription","volume":"7","author":"Kobayashi","year":"2016","journal-title":"Nat Commun"},{"key":"2026021804181373600_ehf215406-bib-0016","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1042\/BST20150014","article-title":"Dissecting molecular cross-talk between Nrf2 and NF-\u03baB response pathways","volume":"43","author":"Wardyn","year":"2015","journal-title":"Biochem Soc Trans"},{"key":"2026021804181373600_ehf215406-bib-0017","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1007\/s12035-017-0389-6","article-title":"Carnosic acid induces anti-inflammatory effects in paraquat-treated SH-SY5Y cells through a mechanism involving a crosstalk between the Nrf2\/HO-1 axis and NF-\u03baB","volume":"55","author":"de Oliveira","year":"2018","journal-title":"Mol Neurobiol"},{"key":"2026021804181373600_ehf215406-bib-0018","doi-asserted-by":"publisher","first-page":"10852","DOI":"10.1039\/D0FO01909G","article-title":"Akebia saponin D suppresses inflammation in chondrocytes via the NRF2\/HO-1\/NF-\u03baB axis and ameliorates osteoarthritis in mice","volume":"11","author":"Gu","year":"2020","journal-title":"Food Funct"},{"key":"2026021804181373600_ehf215406-bib-0019","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/5695723","article-title":"The Nrf-2\/HO-1 signaling axis: a ray of hope in cardiovascular diseases","volume":"2020","author":"Zhang","year":"2020","journal-title":"Cardiol Res Pract"},{"key":"2026021804181373600_ehf215406-bib-0020","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1007\/s10557-020-07071-0","article-title":"Inflammatory cytokines and chemokines as therapeutic targets in heart failure","volume":"34","author":"Hanna","year":"2020","journal-title":"Cardiovasc Drugs Ther"},{"key":"2026021804181373600_ehf215406-bib-0021","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01592","article-title":"Regulatory mechanisms of the NLRP3 inflammasome, a novel immune-inflammatory marker in cardiovascular diseases","volume":"10","author":"An","year":"2019","journal-title":"Front Immunol"},{"key":"2026021804181373600_ehf215406-bib-0022","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.865772","article-title":"Targeting NLRP3 inflammasome with Nrf2 inducers in central nervous system disorders","volume":"13","author":"Tastan","year":"2022","journal-title":"Front Immunol"},{"key":"2026021804181373600_ehf215406-bib-0023","doi-asserted-by":"publisher","DOI":"10.1186\/s12872-023-03442-1","article-title":"Allicin protects against LPS-induced cardiomyocyte injury by activating Nrf2-HO-1 and inhibiting NLRP3 pathways","volume":"23","author":"Sun","year":"2023","journal-title":"BMC Cardiovasc Disord"},{"key":"2026021804181373600_ehf215406-bib-0024","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25052667","article-title":"Mitochondrial dysfunction in heart failure: from pathophysiological mechanisms to therapeutic opportunities","volume":"25","author":"Gallo","year":"2024","journal-title":"Int J Mol Sci"},{"key":"2026021804181373600_ehf215406-bib-0025","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.freeradbiomed.2021.12.001","article-title":"Nrf2 for protection against oxidant generation and mitochondrial damage in cardiac injury","volume":"179","author":"Chen","year":"2022","journal-title":"Free Radic Biol Med"},{"key":"2026021804181373600_ehf215406-bib-0026","doi-asserted-by":"publisher","first-page":"4861","DOI":"10.1093\/hmg\/ddq419","article-title":"Mitofusin 1 and mitofusin 2 are ubiquitinated in a PINK1\/parkin-dependent manner upon induction of mitophagy","volume":"19","author":"Gegg","year":"2010","journal-title":"Hum Mol Genet"},{"key":"2026021804181373600_ehf215406-bib-0027","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.freeradbiomed.2022.01.012","article-title":"Mitochondrial oxidative stress mediated Fe-induced ferroptosis via the NRF2-ARE pathway","volume":"180","author":"Chen","year":"2022","journal-title":"Free Radic Biol Med"},{"key":"2026021804181373600_ehf215406-bib-0028","doi-asserted-by":"publisher","DOI":"10.1126\/science.aau6977","article-title":"The biology, function, and biomedical applications of exosomes","volume":"367","author":"Kalluri","year":"2020","journal-title":"Science"},{"key":"2026021804181373600_ehf215406-bib-0029","doi-asserted-by":"publisher","DOI":"10.1080\/20013078.2019.1698795","article-title":"MiR155-5p in adventitial fibroblasts-derived extracellular vesicles inhibits vascular smooth muscle cell proliferation via suppressing angiotensin-converting enzyme expression","volume":"9","author":"Ren","year":"2020","journal-title":"J Extracell Vesicles"},{"key":"2026021804181373600_ehf215406-bib-0030","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1161\/CIRCULATIONAHA.108.813576","article-title":"Reciprocal regulation of myocardial microRNAs and messenger RNA in human cardiomyopathy and reversal of the microRNA signature by biomechanical support","volume":"119","author":"Matkovich","year":"2009","journal-title":"Circulation"},{"key":"2026021804181373600_ehf215406-bib-0031","doi-asserted-by":"publisher","first-page":"811","DOI":"10.7150\/ijbs.4439","article-title":"Human circulating microRNA-1 and microRNA-126 as potential novel indicators for acute myocardial infarction","volume":"8","author":"Long","year":"2012","journal-title":"Int J Biol Sci"},{"key":"2026021804181373600_ehf215406-bib-0032","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1007\/s12192-014-0565-9","article-title":"MicroRNA-1 aggravates cardiac oxidative stress by post-transcriptional modification of the antioxidant network","volume":"20","author":"Wang","year":"2015","journal-title":"Cell Stress Chaperones"},{"key":"2026021804181373600_ehf215406-bib-0033","doi-asserted-by":"publisher","first-page":"H928","DOI":"10.1152\/ajpheart.00602.2017","article-title":"Myocardial infarction-induced microRNA-enriched exosomes contribute to cardiac Nrf2 dysregulation in chronic heart failure","volume":"314","author":"Tian","year":"2018","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2026021804181373600_ehf215406-bib-0034","doi-asserted-by":"publisher","first-page":"2381","DOI":"10.1016\/j.cellsig.2014.07.016","article-title":"MicroRNA-200a controls Nrf2 activation by target Keap1 in hepatic stellate cell proliferation and fibrosis","volume":"26","author":"Yang","year":"2014","journal-title":"Cell Signal"},{"key":"2026021804181373600_ehf215406-bib-0035","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2020.00263","article-title":"Down-regulated exosomal MicroRNA-221\u20133p derived from senescent mesenchymal stem cells impairs heart repair","volume":"8","author":"Sun","year":"2020","journal-title":"Front Cell Dev Biol"},{"key":"2026021804181373600_ehf215406-bib-0036","doi-asserted-by":"publisher","first-page":"35028","DOI":"10.18632\/oncotarget.26164","article-title":"Chronic heart failure is characterized by altered mitochondrial function and structure in circulating leucocytes","volume":"9","author":"Coluccia","year":"2018","journal-title":"Oncotarget"},{"key":"2026021804181373600_ehf215406-bib-0037","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.763760","article-title":"Nrf2 promotes inflammation in early myocardial ischemia-reperfusion via recruitment and activation of macrophages","volume":"12","author":"Zhang","year":"2021","journal-title":"Front Immunol"},{"key":"2026021804181373600_ehf215406-bib-0038","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1038\/ncpcardio1364","article-title":"Circulating white blood cells and platelets amplify oxidative stress in heart failure","volume":"5","author":"Ijsselmuiden","year":"2008","journal-title":"Nat Rev Cardiol"},{"key":"2026021804181373600_ehf215406-bib-0039","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2023.1206527","article-title":"Nrf2 and autonomic dysregulation in chronic heart failure and hypertension","volume":"14","author":"Wafi","year":"2023","journal-title":"Front Physiol"},{"key":"2026021804181373600_ehf215406-bib-0040","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2012.00335","article-title":"Oxidative stress in the brain causes hypertension via sympathoexcitation","volume":"3","author":"Kishi","year":"2012","journal-title":"Front Physiol"},{"key":"2026021804181373600_ehf215406-bib-0041","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1016\/j.bbadis.2019.01.020","article-title":"Nrf2 deficiency aggravates angiotensin II-induced cardiac injury by increasing hypertrophy and enhancing IL-6\/STAT3-dependent inflammation","volume":"1865","author":"Chen","year":"2019","journal-title":"Biochim Biophys Acta Mol basis Dis"},{"key":"2026021804181373600_ehf215406-bib-0042","doi-asserted-by":"publisher","DOI":"10.1111\/acel.13453","article-title":"Chronic low-grade inflammation in heart failure with preserved ejection fraction","volume":"20","author":"Mesquita","year":"2021","journal-title":"Aging Cell"},{"key":"2026021804181373600_ehf215406-bib-0043","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2021.107819","article-title":"Nitrite and myocardial ischaemia reperfusion injury. Where are we now?","volume":"223","author":"Griffiths","year":"2021","journal-title":"Pharmacol Ther"},{"key":"2026021804181373600_ehf215406-bib-0044","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.molmed.2020.10.002","article-title":"Intercellular communication in the heart: therapeutic opportunities for cardiac ischemia","volume":"27","author":"Martins-Marques","year":"2021","journal-title":"Trends Mol Med"},{"key":"2026021804181373600_ehf215406-bib-0045","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1007\/s00395-021-00852-0","article-title":"Does remote ischaemic conditioning reduce inflammation? A focus on innate immunity and cytokine response","volume":"116","author":"Pearce","year":"2021","journal-title":"Basic Res Cardiol"},{"key":"2026021804181373600_ehf215406-bib-0046","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.neuropharm.2013.11.004","article-title":"NRF2-regulation in brain health and disease: implication of cerebral inflammation","volume":"79","author":"Sandberg","year":"2014","journal-title":"Neuropharmacology"},{"key":"2026021804181373600_ehf215406-bib-0047","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.yjmcc.2010.05.011","article-title":"4-Hydroxy-2-nonenal protects against cardiac ischemia-reperfusion injury via the Nrf2-dependent pathway","volume":"49","author":"Zhang","year":"2010","journal-title":"J Mol Cell Cardiol"},{"key":"2026021804181373600_ehf215406-bib-0048","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.freeradbiomed.2013.04.007","article-title":"The transcription factor Nrf2 promotes survival by enhancing the expression of uncoupling protein 3 under conditions of oxidative stress","volume":"61","author":"Anedda","year":"2013","journal-title":"Free Radic Biol Med"},{"key":"2026021804181373600_ehf215406-bib-0049","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.115855","article-title":"Nrf2 for a key member of redox regulation: a novel insight against myocardial ischemia and reperfusion injuries","volume":"168","author":"Han","year":"2023","journal-title":"Biomed Pharmacother"},{"key":"2026021804181373600_ehf215406-bib-0050","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1159\/000481755","article-title":"Remote limb ischaemic postconditioning protects against myocardial ischaemia\/reperfusion injury in mice: activation of JAK\/STAT3-mediated Nrf2-antioxidant signalling","volume":"43","author":"Gao","year":"2017","journal-title":"Cell Physiol Biochem"},{"key":"2026021804181373600_ehf215406-bib-0051","doi-asserted-by":"publisher","DOI":"10.1177\/0963689720920830","article-title":"Cardiovascular changes associated with hypertensive heart disease and aging","volume":"29","author":"Saheera","year":"2020","journal-title":"Cell Transplant"},{"key":"2026021804181373600_ehf215406-bib-0052","doi-asserted-by":"publisher","first-page":"823","DOI":"10.3390\/ijms16010823","article-title":"Pathogenesis of target organ damage in hypertension: role of mitochondrial oxidative stress","volume":"16","author":"Rubattu","year":"2014","journal-title":"Int J Mol Sci"},{"key":"2026021804181373600_ehf215406-bib-0053","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1152\/physiolgenomics.00041.2017","article-title":"Nrf2 at the heart of oxidative stress and cardiac protection","volume":"50","author":"Chen","year":"2018","journal-title":"Physiol Genomics"},{"key":"2026021804181373600_ehf215406-bib-0054","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23084382","article-title":"Nrf2-activating bioactive peptides exert anti-inflammatory activity through inhibition of the NF-\u03baB pathway","volume":"23","author":"Tonolo","year":"2022","journal-title":"Int J Mol Sci"},{"key":"2026021804181373600_ehf215406-bib-0055","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1161\/ATVBAHA.109.189480","article-title":"Nrf2 protects against maladaptive cardiac responses to hemodynamic stress","volume":"29","author":"Li","year":"2009","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2026021804181373600_ehf215406-bib-0056","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1016\/j.cardfail.2009.02.003","article-title":"Upregulating the heme oxygenase system suppresses left ventricular hypertrophy in adult spontaneously hypertensive rats for 3 months","volume":"15","author":"Ndisang","year":"2009","journal-title":"J Card Fail"},{"key":"2026021804181373600_ehf215406-bib-0057","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1152\/japplphysiol.01392.2010","article-title":"Exercise-induced adaptations of cardiac redox homeostasis and remodeling in heterozygous SOD2-knockout mice","volume":"111","author":"Richters","year":"2011","journal-title":"J Appl Physiol"},{"key":"2026021804181373600_ehf215406-bib-0058","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.1057918","article-title":"Activation of Nrf2 signaling: a key molecular mechanism of protection against cardiovascular diseases by natural products","volume":"13","author":"Wu","year":"2022","journal-title":"Front Pharmacol"},{"key":"2026021804181373600_ehf215406-bib-0059","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/260429","article-title":"The role of Nrf2-mediated pathway in cardiac remodeling and heart failure","volume":"2014","author":"Zhou","year":"2014","journal-title":"Oxidative Med Cell Longev"},{"key":"2026021804181373600_ehf215406-bib-0060","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1161\/HYPERTENSIONAHA.117.09123","article-title":"Selective Nrf2 gene deletion in the rostral ventrolateral medulla evokes hypertension and sympathoexcitation in mice","volume":"69","author":"Gao","year":"2017","journal-title":"Hypertension"},{"key":"2026021804181373600_ehf215406-bib-0061","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1161\/CIRCRESAHA.117.311586","article-title":"Diabetic cardiomyopathy: an update of mechanisms contributing to this clinical entity","volume":"122","author":"Jia","year":"2018","journal-title":"Circ Res"},{"key":"2026021804181373600_ehf215406-bib-0062","doi-asserted-by":"publisher","first-page":"625","DOI":"10.2337\/db10-1164","article-title":"Diabetic downregulation of Nrf2 activity via ERK contributes to oxidative stress-induced insulin resistance in cardiac cells in vitro and in vivo","volume":"60","author":"Tan","year":"2011","journal-title":"Diabetes"},{"key":"2026021804181373600_ehf215406-bib-0063","doi-asserted-by":"publisher","first-page":"2463","DOI":"10.2337\/db22-0623","article-title":"NRF2 and diabetes: the good, the bad, and the complex","volume":"71","author":"Dodson","year":"2022","journal-title":"Diabetes"},{"key":"2026021804181373600_ehf215406-bib-0064","doi-asserted-by":"publisher","DOI":"10.4172\/2155-6156.S7-002","article-title":"Disruption of Nrf2 synergizes with high glucose to cause heightened myocardial oxidative stress and severe cardiomyopathy in diabetic mice","volume":"7","author":"He","year":"2012","journal-title":"J Diabetes Metab"},{"key":"2026021804181373600_ehf215406-bib-0065","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.18055","article-title":"Cardioprotective effects of asiaticoside against diabetic cardiomyopathy: activation of the AMPK\/Nrf2 pathway","volume":"28","author":"Xu","year":"2024","journal-title":"J Cell Mol Med"},{"key":"2026021804181373600_ehf215406-bib-0066","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0075927","article-title":"Heme oxygenase-1 prevents cardiac dysfunction in streptozotocin-diabetic mice by reducing inflammation, oxidative stress, apoptosis and enhancing autophagy","volume":"8","author":"Zhao","year":"2013","journal-title":"PLoS ONE"},{"key":"2026021804181373600_ehf215406-bib-0067","doi-asserted-by":"publisher","first-page":"H2237","DOI":"10.1152\/ajpheart.00427.2006","article-title":"Overexpression of glutathione peroxidase attenuates myocardial remodeling and preserves diastolic function in diabetic heart","volume":"291","author":"Matsushima","year":"2006","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2026021804181373600_ehf215406-bib-0068","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.31149","article-title":"Nrf2 prevents diabetic cardiomyopathy via antioxidant effect and normalization of glucose and lipid metabolism in the heart","volume":"239","author":"Yang","year":"2024","journal-title":"J Cell Physiol"},{"key":"2026021804181373600_ehf215406-bib-0069","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1228045","article-title":"The role of autophagy in the treatment of type II diabetes and its complications: a review","volume":"14","author":"Zhao","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2026021804181373600_ehf215406-bib-0070","doi-asserted-by":"publisher","DOI":"10.1186\/s13098-023-01135-5","article-title":"Iron accumulation and lipid peroxidation: implication of ferroptosis in diabetic cardiomyopathy","volume":"15","author":"Yan","year":"2023","journal-title":"Diabetol Metab Syndr"},{"key":"2026021804181373600_ehf215406-bib-0071","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1421838","article-title":"Ferroptosis in diabetic cardiomyopathy: from its mechanisms to therapeutic strategies","volume":"15","author":"Tian","year":"2024","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2026021804181373600_ehf215406-bib-0072","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/j.chembiol.2020.03.011","article-title":"Breakdown of an ironclad defense system: the critical role of NRF2 in mediating ferroptosis","volume":"27","author":"Anandhan","year":"2020","journal-title":"Cell Chem Biol"},{"key":"2026021804181373600_ehf215406-bib-0073","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/3159717","article-title":"Curcumin attenuates ferroptosis-induced myocardial injury in diabetic cardiomyopathy through the Nrf2 pathway","volume":"2022","author":"Wei","year":"2022","journal-title":"Cardiovasc Ther"},{"key":"2026021804181373600_ehf215406-bib-0074","doi-asserted-by":"publisher","DOI":"10.31083\/j.rcm2405148","article-title":"Anthracyclines-induced cardiac dysfunction: what every clinician should know","volume":"24","author":"Ferrera","year":"2023","journal-title":"Rev Cardiovasc Med"},{"key":"2026021804181373600_ehf215406-bib-0075","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/748524","article-title":"Nrf2 deficiency exaggerates doxorubicin-induced cardiotoxicity and cardiac dysfunction","volume":"2014","author":"Li","year":"2014","journal-title":"Oxidative Med Cell Longev"},{"key":"2026021804181373600_ehf215406-bib-0076","doi-asserted-by":"publisher","DOI":"10.3390\/nu14194017","article-title":"Resveratrol and FGF1 synergistically ameliorates doxorubicin-induced cardiotoxicity via activation of SIRT1-NRF2 pathway","volume":"14","author":"Lu","year":"2022","journal-title":"Nutrients"},{"key":"2026021804181373600_ehf215406-bib-0077","doi-asserted-by":"publisher","DOI":"10.1038\/s41420-023-01565-0","article-title":"Nrf2: a dark horse in doxorubicin-induced cardiotoxicity","volume":"9","author":"Zhao","year":"2023","journal-title":"Cell Death Dis"},{"key":"2026021804181373600_ehf215406-bib-0078","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1007\/s12012-020-09581-7","article-title":"Disruption of the Keap1\/Nrf2-antioxidant response system after chronic doxorubicin exposure in vivo","volume":"20","author":"Nordgren","year":"2020","journal-title":"Cardiovasc Toxicol"},{"key":"2026021804181373600_ehf215406-bib-0079","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/8860883","article-title":"Activation of Nrf2 by miR-152 inhibits doxorubicin-induced cardiotoxicity via attenuation of oxidative stress, inflammation, and apoptosis","volume":"2021","author":"Zhang","year":"2021","journal-title":"Oxidative Med Cell Longev"},{"key":"2026021804181373600_ehf215406-bib-0080","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S1071-9164(96)80002-9","article-title":"Spirals, paradigms, and the progression of heart failure","volume":"2","author":"Poole-Wilson","year":"1996","journal-title":"J Card Fail"},{"key":"2026021804181373600_ehf215406-bib-0081","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.smhs.2021.04.002","article-title":"Harnessing the cardiovascular benefits of exercise: are Nrf2 activators useful?","volume":"3","author":"Fasipe","year":"2021","journal-title":"Sports Med Health Sci"},{"key":"2026021804181373600_ehf215406-bib-0082","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.freeradbiomed.2011.10.440","article-title":"Acute exercise stress activates Nrf2\/ARE signaling and promotes antioxidant mechanisms in the myocardium","volume":"52","author":"Muthusamy","year":"2012","journal-title":"Free Radic Biol Med"},{"key":"2026021804181373600_ehf215406-bib-0083","doi-asserted-by":"publisher","DOI":"10.1007\/s00395-022-00941-8","article-title":"Why is endothelial resilience key to maintain cardiac health?","volume":"117","author":"Tombor","year":"2022","journal-title":"Basic Res Cardiol"},{"key":"2026021804181373600_ehf215406-bib-0084","doi-asserted-by":"publisher","first-page":"5195","DOI":"10.1113\/JP271957","article-title":"Nuclear factor erythroid-derived 2-like 2 (NFE2L2, Nrf2) mediates exercise-induced mitochondrial biogenesis and the anti-oxidant response in mice","volume":"594","author":"Merry","year":"2016","journal-title":"J Physiol"},{"key":"2026021804181373600_ehf215406-bib-0085","doi-asserted-by":"publisher","DOI":"10.3390\/antiox11050826","article-title":"Physical-exercise-induced antioxidant effects on the brain and skeletal muscle","volume":"11","author":"Souza","year":"2022","journal-title":"Antioxidants"},{"key":"2026021804181373600_ehf215406-bib-0086","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.freeradbiomed.2016.04.024","article-title":"Exercise-induced Nrf2-signaling is impaired in aging","volume":"96","author":"Done","year":"2016","journal-title":"Free Radic Biol Med"},{"key":"2026021804181373600_ehf215406-bib-0087","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.freeradbiomed.2021.05.039","article-title":"High intensity muscle stimulation activates a systemic Nrf2-mediated redox stress response","volume":"172","author":"Ostrom","year":"2021","journal-title":"Free Radic Biol Med"},{"key":"2026021804181373600_ehf215406-bib-0088","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.freeradbiomed.2016.02.025","article-title":"Exercise-induced hormesis and skeletal muscle health","volume":"98","author":"Ji","year":"2016","journal-title":"Free Radic Biol Med"},{"key":"2026021804181373600_ehf215406-bib-0089","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.freeradbiomed.2015.11.032","article-title":"Mitohormesis in exercise training","volume":"98","author":"Merry","year":"2016","journal-title":"Free Radic Biol Med"},{"key":"2026021804181373600_ehf215406-bib-0090","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/s40292-025-00707-y","article-title":"Monitoring the effects of cardiac rehabilitation programs in heart failure patients: the role of biomarkers","volume":"32","author":"Gallo","year":"2025","journal-title":"High Blood Press Cardiovasc Prev"},{"key":"2026021804181373600_ehf215406-bib-0091","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1080\/10408398.2022.2118226","article-title":"Modulation of integrin receptor by polyphenols: downstream Nrf2-Keap1\/ARE and associated cross-talk mediators in cardiovascular diseases","volume":"64","author":"Fakhri","year":"2024","journal-title":"Crit Rev Food Sci Nutr"},{"key":"2026021804181373600_ehf215406-bib-0092","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1152\/physiolgenomics.00079.2021","article-title":"Nrf2 signaling in heart failure: expression of Nrf2, Keap1, antioxidant, and detoxification genes in dilated or ischemic cardiomyopathy","volume":"54","author":"Lu","year":"2022","journal-title":"Physiol Genomics"},{"key":"2026021804181373600_ehf215406-bib-0093","doi-asserted-by":"publisher","DOI":"10.1177\/1178638819882739","article-title":"The effects of dietary polyphenols on circulating cardiovascular disease biomarkers and iron status: a systematic review","volume":"12","author":"Speer","year":"2019","journal-title":"Nutr Metab Insights"},{"key":"2026021804181373600_ehf215406-bib-0094","doi-asserted-by":"publisher","first-page":"323","DOI":"10.4238\/2014.January.17.17","article-title":"Resveratrol, an activator of SIRT1, upregulates AMPK and improves cardiac function in heart failure","volume":"13","author":"Gu","year":"2014","journal-title":"Genet Mol Res"},{"key":"2026021804181373600_ehf215406-bib-0095","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/2150218","article-title":"Resveratrol prevents diabetic cardiomyopathy by increasing Nrf2 expression and transcriptional activity","volume":"2018","author":"Wang","year":"2018","journal-title":"Biomed Res Int"},{"key":"2026021804181373600_ehf215406-bib-0096","doi-asserted-by":"publisher","first-page":"8375","DOI":"10.1074\/jbc.M109.090266","article-title":"Induction of manganese superoxide dismutase by nuclear translocation and activation of SIRT1 promotes cell survival in chronic heart failure","volume":"285","author":"Tanno","year":"2010","journal-title":"J Biol Chem"},{"key":"2026021804181373600_ehf215406-bib-0097","doi-asserted-by":"publisher","first-page":"H833","DOI":"10.1152\/ajpheart.00418.2009","article-title":"Resveratrol, an activator of SIRT1, upregulates sarcoplasmic calcium ATPase and improves cardiac function in diabetic cardiomyopathy","volume":"298","author":"Sulaiman","year":"2010","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2026021804181373600_ehf215406-bib-0098","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1142\/S0192415X22500537","article-title":"Quercetin mitigates cisplatin-induced oxidative damage and apoptosis in cardiomyocytes through Nrf2\/HO-1 signaling pathway","volume":"50","author":"Wang","year":"2022","journal-title":"Am J Chin Med"},{"key":"2026021804181373600_ehf215406-bib-0099","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.01118","article-title":"Kaempferol protects blood vessels from damage induced by oxidative stress and inflammation in association with the Nrf2\/HO-1 signaling pathway","volume":"11","author":"Yao","year":"2020","journal-title":"Front Pharmacol"},{"key":"2026021804181373600_ehf215406-bib-0100","doi-asserted-by":"publisher","DOI":"10.3390\/molecules27134145","article-title":"The therapeutic potential of kaemferol and other naturally occurring polyphenols might be modulated by Nrf2-ARE signaling pathway: current status and future direction","volume":"27","author":"Hussain","year":"2022","journal-title":"Molecules"},{"key":"2026021804181373600_ehf215406-bib-0101","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1097\/FJC.0000000000000713","article-title":"Kaempferol prevents against Ang II-induced cardiac remodeling through attenuating Ang II-induced inflammation and oxidative stress","volume":"74","author":"Du","year":"2019","journal-title":"J Cardiovasc Pharmacol"},{"key":"2026021804181373600_ehf215406-bib-0102","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1497733","article-title":"Calycosin alleviates ferroptosis and attenuates doxorubicin-induced myocardial injury via the Nrf2\/SLC7A11\/GPX4 signaling pathway","volume":"15","author":"Han","year":"2024","journal-title":"Front Pharmacol"},{"key":"2026021804181373600_ehf215406-bib-0103","doi-asserted-by":"publisher","first-page":"2935","DOI":"10.1039\/c7fo00342k","article-title":"Soybean isoflavones ameliorate ischemic cardiomyopathy by activating Nrf2-mediated antioxidant responses","volume":"8","author":"Li","year":"2017","journal-title":"Food Funct"},{"key":"2026021804181373600_ehf215406-bib-0104","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.lfs.2016.02.048","article-title":"Therapeutic potential of chalcones as cardiovascular agents","volume":"148","author":"Mahapatra","year":"2016","journal-title":"Life Sci"},{"key":"2026021804181373600_ehf215406-bib-0105","doi-asserted-by":"publisher","first-page":"11083","DOI":"10.1039\/d4fo03543g","article-title":"Cardamonin protects against diabetic cardiomyopathy by activating macrophage NRF2 signaling through molecular interaction with KEAP1","volume":"15","author":"Nan","year":"2024","journal-title":"Food Funct"},{"key":"2026021804181373600_ehf215406-bib-0106","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1038\/s41401-020-0397-3","article-title":"Cardamonin protects against lipopolysaccharide-induced myocardial contractile dysfunction in mice through Nrf2-regulated mechanism","volume":"42","author":"Tan","year":"2021","journal-title":"Acta Pharmacol Sin"},{"key":"2026021804181373600_ehf215406-bib-0107","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/8684014","article-title":"Butein inhibits oxidative stress injury in rats with chronic heart failure via ERK\/Nrf2 signaling","volume":"2022","author":"Liu","year":"2022","journal-title":"Cardiovasc Ther"},{"key":"2026021804181373600_ehf215406-bib-0108","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1016\/j.apsb.2021.10.005","article-title":"Ferroptosis is essential for diabetic cardiomyopathy and is prevented by sulforaphane via AMPK\/NRF2 pathways","volume":"12","author":"Wang","year":"2022","journal-title":"Acta Pharm Sin B"},{"key":"2026021804181373600_ehf215406-bib-0109","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2022.120780","article-title":"Essential role of Nrf2 in sulforaphane-induced protection against angiotensin II-induced aortic injury","volume":"306","author":"Wang","year":"2022","journal-title":"Life Sci"},{"key":"2026021804181373600_ehf215406-bib-0110","doi-asserted-by":"publisher","first-page":"6740","DOI":"10.18632\/aging.204247","article-title":"Sulforaphane inhibits angiotensin II-induced cardiomyocyte apoptosis by acetylation modification of Nrf2","volume":"14","author":"Wang","year":"2022","journal-title":"Aging (Albany NY)"},{"key":"2026021804181373600_ehf215406-bib-0111","doi-asserted-by":"publisher","first-page":"4408","DOI":"10.1111\/jcmm.16504","article-title":"Sulforaphane prevents angiotensin II-induced cardiomyopathy by activation of Nrf2 through epigenetic modification","volume":"25","author":"Su","year":"2021","journal-title":"J Cell Mol Med"},{"key":"2026021804181373600_ehf215406-bib-0112","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1016\/j.jnutbio.2009.11.001","article-title":"Allicin protects against cardiac hypertrophy and fibrosis via attenuating reactive oxygen species-dependent signaling pathways","volume":"21","author":"Liu","year":"2010","journal-title":"J Nutr Biochem"},{"key":"2026021804181373600_ehf215406-bib-0113","doi-asserted-by":"publisher","first-page":"529","DOI":"10.3390\/hearts5040039","article-title":"Double duty: SGLT2 inhibitors as cardioprotective and anticancer allies","volume":"5","author":"Piras","year":"2024","journal-title":"Heart"},{"key":"2026021804181373600_ehf215406-bib-0114","doi-asserted-by":"publisher","DOI":"10.3390\/ijms231710146","article-title":"Dapagliflozin mitigates doxorubicin-caused myocardium damage by regulating AKT-mediated oxidative stress, cardiac remodeling, and Inflammation","volume":"23","author":"Hsieh","year":"2022","journal-title":"Int J Mol Sci"},{"key":"2026021804181373600_ehf215406-bib-0115","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0317295","article-title":"Dapagliflozin inhibits ferroptosis to improve chronic heart failure by regulating Nrf2\/HO-1\/GPX4 signaling pathway","volume":"20","author":"Zhang","year":"2025","journal-title":"PLoS ONE"},{"key":"2026021804181373600_ehf215406-bib-0116","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/1122494","article-title":"Empagliflozin ameliorates diabetic cardiomyopathy via attenuating oxidative stress and improving mitochondrial function","volume":"2022","author":"Wang","year":"2022","journal-title":"Oxidative Med Cell Longev"},{"key":"2026021804181373600_ehf215406-bib-0117","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-71449-1","article-title":"Canagliflozin attenuates isoprenaline-induced cardiac oxidative stress by stimulating multiple antioxidant and anti-inflammatory signaling pathways","volume":"10","author":"Hasan","year":"2020","journal-title":"Sci Rep"},{"key":"2026021804181373600_ehf215406-bib-0118","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2024.107268","article-title":"Nrf2 mediated signaling axis in heart failure: potential pharmacological receptor","volume":"206","author":"Cheng","year":"2024","journal-title":"Pharmacol Res"},{"key":"2026021804181373600_ehf215406-bib-0119","doi-asserted-by":"publisher","DOI":"10.1186\/s13578-021-00547-y","article-title":"Dapagliflozin attenuates hypoxia\/reoxygenation-caused cardiac dysfunction and oxidative damage through modulation of AMPK","volume":"11","author":"Tsai","year":"2021","journal-title":"Cell Biosci"},{"key":"2026021804181373600_ehf215406-bib-0120","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1002\/ehf2.15186","article-title":"Vericiguat improves cardiac remodelling and function in rats with doxorubicin-induced cardiomyopathy","volume":"12","author":"Chen","year":"2025","journal-title":"ESC Heart Fail"},{"key":"2026021804181373600_ehf215406-bib-0121","doi-asserted-by":"publisher","first-page":"2004","DOI":"10.1002\/tox.22374","article-title":"Protection of Nrf2 against arsenite-induced oxidative damage is regulated by the cyclic guanosine monophosphate-protein kinase G signaling pathway","volume":"32","author":"Chen","year":"2017","journal-title":"Environ Toxicol"},{"key":"2026021804181373600_ehf215406-bib-0122","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/S0022-3565(24)39002-0","article-title":"Effects of carvedilol and its analog BM-910228 on mitochondrial function and oxidative stress","volume":"295","author":"Abreu","year":"2000","journal-title":"J Pharmacol Exp Ther"},{"key":"2026021804181373600_ehf215406-bib-0123","doi-asserted-by":"publisher","DOI":"10.3390\/antiox12081585","article-title":"Carvedilol phenocopies PGC-1\u03b1 overexpression to alleviate oxidative stress, mitochondrial dysfunction and prevent doxorubicin-induced toxicity in human iPSC-derived cardiomyocytes","volume":"12","author":"Uche","year":"2023","journal-title":"Antioxidants (Basel)"},{"key":"2026021804181373600_ehf215406-bib-0124","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1016\/j.bbrc.2013.10.160","article-title":"Carvedilol, a third-generation \u03b2-blocker prevents oxidative stress-induced neuronal death and activates Nrf2\/ARE pathway in HT22 cells","volume":"441","author":"Ouyang","year":"2013","journal-title":"Biochem Biophys Res Commun"},{"key":"2026021804181373600_ehf215406-bib-0125","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1080\/08923973.2024.2435323","article-title":"Combined bisoprolol and trimetazidine ameliorate arsenic trioxide -induced acute myocardial injury in rats: targeting PI3K\/GSK-3\u03b2\/Nrf2\/HO-1 and NF-\u03baB\/iNOS signaling pathways, inflammatory mediators and apoptosis","volume":"47","author":"Ahmed","year":"2025","journal-title":"Immunopharmacol Immunotoxicol"},{"key":"2026021804181373600_ehf215406-bib-0126","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25073683","article-title":"Propranolol promotes monocyte-to-macrophage differentiation and enhances macrophage anti-inflammatory and antioxidant activities by NRF2 activation","volume":"25","author":"Maccari","year":"2024","journal-title":"Int J Mol Sci"},{"key":"2026021804181373600_ehf215406-bib-0127","doi-asserted-by":"publisher","first-page":"e895","DOI":"10.1161\/CIR.0000000000001063","article-title":"2022 AHA\/ACC\/HFSA guideline for the management of heart failure: a report of the American College of Cardiology\/American Heart Association joint committee on clinical practice guidelines","volume":"145","author":"Heidenreich","year":"2022","journal-title":"Circulation"},{"key":"2026021804181373600_ehf215406-bib-0128","doi-asserted-by":"publisher","DOI":"10.3390\/antiox13080955","article-title":"Eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) ameliorate heart failure through reductions in oxidative stress: a systematic review and meta-analysis","volume":"13","author":"Seth","year":"2024","journal-title":"Antioxidants"},{"key":"2026021804181373600_ehf215406-bib-0129","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0187934","article-title":"Fish oil omega-3 polyunsaturated fatty acids attenuate oxidative stress-induced DNA damage in vascular endothelial cells","volume":"12","author":"Sakai","year":"2017","journal-title":"PLoS ONE"},{"key":"2026021804181373600_ehf215406-bib-0130","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.123.010805","article-title":"Coronary microvascular dysfunction in patients with heart failure: characterization of patterns in HFrEF versus HFpEF","volume":"17","author":"Paolisso","year":"2024","journal-title":"Circ Heart Fail"},{"key":"2026021804181373600_ehf215406-bib-0131","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/j.freeradbiomed.2016.09.009","article-title":"Ezetimibe, an NPC1L1 inhibitor, is a potent Nrf2 activator that protects mice from diet-induced nonalcoholic steatohepatitis","volume":"99","author":"Lee","year":"2016","journal-title":"Free Radic Biol Med"},{"key":"2026021804181373600_ehf215406-bib-0132","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1111\/fcp.13029","article-title":"The therapeutic effect of NRF2 activator, ezetimibe, in cardiac cachexia","volume":"38","author":"Vashi","year":"2024","journal-title":"Fundam Clin Pharmacol"},{"key":"2026021804181373600_ehf215406-bib-0133","doi-asserted-by":"publisher","first-page":"3853","DOI":"10.2147\/DDDT.S251726","article-title":"Protective effect of pravastatin on myocardial ischemia reperfusion injury by regulation of the miR-93\/Nrf2\/ARE signal pathway","volume":"14","author":"Liu","year":"2020","journal-title":"Drug Des Devel Ther"},{"key":"2026021804181373600_ehf215406-bib-0134","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.yjmcc.2015.03.004","article-title":"Rosuvastatin suppresses atrial tachycardia-induced cellular remodeling via Akt\/Nrf2\/heme oxygenase-1 pathway","volume":"82","author":"Yeh","year":"2015","journal-title":"J Mol Cell Cardiol"},{"key":"2026021804181373600_ehf215406-bib-0135","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s40292-024-00629-1","article-title":"Novel strategies in diagnosing heart failure with preserved ejection fraction: a comprehensive literature review","volume":"31","author":"Mancusi","year":"2024","journal-title":"High Blood Press Cardiovasc Prev"},{"key":"2026021804181373600_ehf215406-bib-0136","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.redox.2018.07.007","article-title":"Melatonin improves cardiac function in a mouse model of heart failure with preserved ejection fraction","volume":"18","author":"Liu","year":"2018","journal-title":"Redox Biol"},{"key":"2026021804181373600_ehf215406-bib-0137","doi-asserted-by":"publisher","DOI":"10.15212\/CVIA.2022.0024","article-title":"Canagliflozin regulates ferroptosis, potentially via activating AMPK\/PGC-1\u03b1\/Nrf2 signalin in HFpEF rats","volume":"7","author":"Ma","year":"2023","journal-title":"Cardiovasc Innov Appl"},{"key":"2026021804181373600_ehf215406-bib-0138","doi-asserted-by":"publisher","first-page":"2567","DOI":"10.1038\/s41401-024-01341-5","article-title":"Geniposide alleviates heart failure with preserved ejection fraction in mice by regulating cardiac oxidative stress via MMP2\/SIRT1\/GSK3\u03b2 pathway","volume":"45","author":"Han","year":"2024","journal-title":"Acta Pharmacol Sin"},{"key":"2026021804181373600_ehf215406-bib-0139","doi-asserted-by":"publisher","first-page":"3553","DOI":"10.1039\/d5fo00475f","article-title":"Dietary limonin ameliorates heart failure with preserved ejection fraction by targeting ferroptosis via modulation of the Nrf2\/SLC7A11\/GPX4 axis: an integrated transcriptomics and metabolomics analysis","volume":"16","author":"Wei","year":"2025","journal-title":"Food Funct"},{"key":"2026021804181373600_ehf215406-bib-0140","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/s41401-023-01152-0","article-title":"Animal models of heart failure with preserved ejection fraction (HFpEF): from metabolic pathobiology to drug discovery","volume":"45","author":"Gao","year":"2024","journal-title":"Acta Pharmacol Sin"},{"key":"2026021804181373600_ehf215406-bib-0141","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-023-04734-y","article-title":"Inhibition of ferroptosis reverses heart failure with preserved ejection fraction in mice","volume":"22","author":"Xiong","year":"2024","journal-title":"J Transl Med"},{"key":"2026021804181373600_ehf215406-bib-0142","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1002\/ana.25934","article-title":"Safety and efficacy of omaveloxolone in Friedreich ataxia (MOXIe study)","volume":"89","author":"Lynch","year":"2021","journal-title":"Ann Neurol"},{"key":"2026021804181373600_ehf215406-bib-0143","doi-asserted-by":"publisher","first-page":"2492","DOI":"10.1056\/NEJMoa1306033","article-title":"Bardoxolone methyl in type 2 diabetes and stage 4 chronic kidney disease","volume":"369","author":"de Zeeuw","year":"2013","journal-title":"N Engl J Med"},{"key":"2026021804181373600_ehf215406-bib-0144","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1002\/mds.30070","article-title":"Omaveloxolone for the treatment of Friedreich ataxia: efficacy, safety, and future perspectives","volume":"40","author":"Naghipour","year":"2025","journal-title":"Mov Disord"},{"key":"2026021804181373600_ehf215406-bib-0145","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1007\/s40120-025-00749-3","article-title":"Safety monitoring of omaveloxolone in Friedreich ataxia: results from one year of clinical treatment","volume":"14","author":"Gunther","year":"2025","journal-title":"Neurol Ther"},{"key":"2026021804181373600_ehf215406-bib-0146","volume-title":"Assessment of cardiac safety in patients with Friedreich's ataxia in the MOXIe trial of omaveloxolone"},{"key":"2026021804181373600_ehf215406-bib-0147","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.124.038505","article-title":"Omaveloxolone, but not dimethyl fumarate, improves cardiac function in Friedreich's ataxia mice with severe cardiomyopathy","volume":"14","author":"Salinas","year":"2025","journal-title":"J Am Heart Assoc"},{"key":"2026021804181373600_ehf215406-bib-0148","doi-asserted-by":"publisher","DOI":"10.3390\/antiox11061112","article-title":"Nrf2 activation in chronic kidney disease: promises and pitfalls","volume":"11","author":"Aranda-Rivera","year":"2022","journal-title":"Antioxidants (Basel)"},{"key":"2026021804181373600_ehf215406-bib-0149","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1016\/j.cardfail.2014.10.001","article-title":"Risk factors for heart failure in patients with type 2 diabetes mellitus and stage 4 chronic kidney disease treated with bardoxolone methyl","volume":"20","author":"Chin","year":"2014","journal-title":"J Card Fail"},{"key":"2026021804181373600_ehf215406-bib-0150","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1159\/000362906","article-title":"Mechanisms contributing to adverse cardiovascular events in patients with type 2 diabetes mellitus and stage 4 chronic kidney disease treated with bardoxolone methyl","volume":"39","author":"Chin","year":"2014","journal-title":"Am J Nephrol"},{"key":"2026021804181373600_ehf215406-bib-0151","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1093\/cvr\/cvt150","article-title":"Nrf2 deficiency prevents reductive stress-induced hypertrophic cardiomyopathy","volume":"100","author":"Kannan","year":"2013","journal-title":"Cardiovasc Res"},{"key":"2026021804181373600_ehf215406-bib-0152","doi-asserted-by":"publisher","DOI":"10.3390\/genes13091514","article-title":"Transgenic expression of Nrf2 induces a pro-reductive stress and adaptive cardiac remodeling in the mouse","volume":"13","author":"Jyothidasan","year":"2022","journal-title":"Genes (Basel)"},{"key":"2026021804181373600_ehf215406-bib-0153","doi-asserted-by":"publisher","first-page":"192","DOI":"10.2741\/4384","article-title":"Nuclear factor erythroid-2 related factor 2 (Nrf2)-mediated protein quality control in cardiomyocytes","volume":"21","author":"Cui","year":"2016","journal-title":"Front Biosci (Landmark Ed)"},{"key":"2026021804181373600_ehf215406-bib-0154","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1161\/HYPERTENSIONAHA.115.06062","article-title":"Nrf2-mediated cardiac maladaptive remodeling and dysfunction in a setting of autophagy insufficiency","volume":"67","author":"Qin","year":"2016","journal-title":"Hypertension"},{"key":"2026021804181373600_ehf215406-bib-0155","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.yjmcc.2014.04.006","article-title":"Nrf2 enhances myocardial clearance of toxic ubiquitinated proteins","volume":"72","author":"Wang","year":"2014","journal-title":"J Mol Cell Cardiol"},{"key":"2026021804181373600_ehf215406-bib-0156","doi-asserted-by":"publisher","first-page":"2130","DOI":"10.1002\/ejhf.3068","article-title":"Qiliqiangxin: a multifaceted holistic treatment for heart failure or a pharmacological probe for the identification of cardioprotective mechanisms?","volume":"25","author":"Packer","year":"2023","journal-title":"Eur J Heart Fail"},{"key":"2026021804181373600_ehf215406-bib-0157","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2020.00722","article-title":"The dark side of Nrf2 in the heart","volume":"11","author":"Zang","year":"2020","journal-title":"Front Physiol"},{"key":"2026021804181373600_ehf215406-bib-0158","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-023-04777-w","article-title":"Atrial natriuretic peptide stimulates autophagy\/mitophagy and improves mitochondrial function in chronic heart failure","volume":"80","author":"Raffa","year":"2023","journal-title":"Cell Mol Life Sci"},{"key":"2026021804181373600_ehf215406-bib-0159","doi-asserted-by":"publisher","first-page":"2295","DOI":"10.1038\/s41591-024-03169-2","article-title":"The traditional Chinese medicine Qiliqiangxin in heart failure with reduced ejection fraction: a randomized, double-blind, placebo-controlled trial","volume":"30","author":"Cheang","year":"2024","journal-title":"Nat Med"},{"key":"2026021804181373600_ehf215406-bib-0160","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/S0140-6736(22)01429-5","article-title":"SGLT-2 inhibitors in patients with heart failure: a comprehensive meta-analysis of five randomised controlled trials","volume":"400","author":"Vaduganathan","year":"2022","journal-title":"Lancet"},{"key":"2026021804181373600_ehf215406-bib-0161","doi-asserted-by":"publisher","DOI":"10.3390\/antiox13010070","article-title":"The multifaceted roles of NRF2 in cancer: friend or foe?","volume":"13","author":"Glorieux","year":"2024","journal-title":"Antioxidants"},{"key":"2026021804181373600_ehf215406-bib-0162","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11111755","article-title":"The role of Nrf2 activity in cancer development and progression","volume":"11","author":"Zimta","year":"2019","journal-title":"Cancers (Basel)"},{"key":"2026021804181373600_ehf215406-bib-0163","doi-asserted-by":"publisher","first-page":"176","DOI":"10.14348\/molcells.2023.2191","article-title":"The multi-faceted consequences of NRF2 activation throughout carcinogenesis","volume":"46","author":"Occhiuto","year":"2023","journal-title":"Mol Cells"},{"key":"2026021804181373600_ehf215406-bib-0164","doi-asserted-by":"publisher","first-page":"15710","DOI":"10.1038\/s41598-025-00480-x","article-title":"Bardoxolone methyl suppressed colorectal cancer cells in vitro by inhibiting the PI3K signaling pathway","volume":"15","author":"Zhang","year":"2025","journal-title":"Sci Rep"},{"key":"2026021804181373600_ehf215406-bib-0165","doi-asserted-by":"publisher","first-page":"2252","DOI":"10.1002\/cam4.2101","article-title":"Nrf2 in cancers: a double-edged sword","volume":"8","author":"Wu","year":"2019","journal-title":"Cancer Med"},{"key":"2026021804181373600_ehf215406-bib-0166","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14102543","article-title":"Mutational activation of the NRF2 pathway upregulates kynureninase resulting in tumor immunosuppression and poor outcome in lung adenocarcinoma","volume":"14","author":"Fahrmann","year":"2022","journal-title":"Cancers (Basel)"},{"key":"2026021804181373600_ehf215406-bib-0167","doi-asserted-by":"publisher","first-page":"142","DOI":"10.14348\/molcells.2023.2183","article-title":"Nrf2 in TIME: the emerging role of nuclear factor erythroid 2-related factor 2 in the tumor immune microenvironment","volume":"46","author":"Feng","year":"2023","journal-title":"Mol Cells"},{"key":"2026021804181373600_ehf215406-bib-0168","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1136\/heartjnl-2022-321545","article-title":"Impact of sodium-glucose cotransporter-2 inhibitors on heart failure and mortality in patients with cancer","volume":"109","author":"Chiang","year":"2023","journal-title":"Heart"},{"key":"2026021804181373600_ehf215406-bib-0169","doi-asserted-by":"publisher","DOI":"10.1093\/ehjcvp\/pvaf028","article-title":"Effects of sodium\u2013glucose cotransporter 2 inhibitors in patients with cancer and diabetes mellitus: a systematic review and meta-analysis","volume":"11","author":"Novo","year":"2025","journal-title":"Eur Heart J Cardiovasc Pharmacother"}],"container-title":["ESC Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eschf\/article-pdf\/12\/6\/4000\/66968230\/eschf_12_6_4000.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eschf\/article-pdf\/12\/6\/4000\/66968230\/eschf_12_6_4000.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T09:18:19Z","timestamp":1771406299000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eschf\/article\/12\/6\/4000\/8488185"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,8]]},"references-count":169,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,9,8]]},"published-print":{"date-parts":[[2025,12,1]]}},"URL":"https:\/\/doi.org\/10.1002\/ehf2.15406","relation":{},"ISSN":["2055-5822"],"issn-type":[{"value":"2055-5822","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,12]]},"published":{"date-parts":[[2025,9,8]]},"assertion":[{"value":"2025-05-06","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-08-11","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-09-08","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}